Consistent with our previous findings in CIP2A-overexpressed mice, the Chk1 overexpression resulted in remarkable synaptic dysfunction and severe cognitive impairment in mice, which mimics the changes in AD patients. The gene discussed is CHEK1; the disease is Cognitive impairment.